rs119481079
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_000197.2(HSD17B3):c.389A>G(p.Asn130Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000109 in 1,613,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000197.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HSD17B3 | ENST00000375263.8 | c.389A>G | p.Asn130Ser | missense_variant | Exon 5 of 11 | 1 | NM_000197.2 | ENSP00000364412.3 | ||
ENSG00000285269 | ENST00000643789.1 | n.*2065A>G | non_coding_transcript_exon_variant | Exon 16 of 22 | ENSP00000494818.1 | |||||
ENSG00000285269 | ENST00000643789.1 | n.*2065A>G | 3_prime_UTR_variant | Exon 16 of 22 | ENSP00000494818.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251442Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135896
GnomAD4 exome AF: 0.000117 AC: 171AN: 1461748Hom.: 0 Cov.: 32 AF XY: 0.000100 AC XY: 73AN XY: 727194
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74352
ClinVar
Submissions by phenotype
Testosterone 17-beta-dehydrogenase deficiency Pathogenic:3
Variant summary: HSD17B3 c.389A>G (p.Asn130Ser) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 251442 control chromosomes. c.389A>G has been reported in the literature in the compound heterozygous and homozygous states in individuals affected with Testosterone 17-beta-dehydrogenase deficiency (e.g. Moghrabi_1998, Phelan_2015, Grimbly_2016, Zhu_2023). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in absent enzyme activity (Moghrabi_1998). The following publications have been ascertained in the context of this evaluation (PMID: 27307783, 9709959, 25740850, 36154887). ClinVar contains an entry for this variant (Variation ID: 4880). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
ACMG:PM1 PM2 PP2 PP3 -
not provided Pathogenic:2
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 130 of the HSD17B3 protein (p.Asn130Ser). This variant is present in population databases (rs119481079, gnomAD 0.007%). This missense change has been observed in individual(s) with 17β-HSD3 deficiency (PMID: 25740850, 27307783, 36154887). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 4880). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HSD17B3 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects HSD17B3 function (PMID: 9709959). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at